375 related articles for article (PubMed ID: 25165162)
1. Functional characterizations of effector protein BipC, a type III secretion system protein, in Burkholderia pseudomallei pathogenesis.
Kang WT; Vellasamy KM; Chua EG; Vadivelu J
J Infect Dis; 2015 Mar; 211(5):827-34. PubMed ID: 25165162
[TBL] [Abstract][Full Text] [Related]
2. Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model.
Warawa J; Woods DE
FEMS Microbiol Lett; 2005 Jan; 242(1):101-8. PubMed ID: 15621426
[TBL] [Abstract][Full Text] [Related]
3. BipC, a Predicted
Vander Broek CW; Zainal Abidin N; Stevens JM
Front Cell Infect Microbiol; 2017; 7():333. PubMed ID: 28770177
[No Abstract] [Full Text] [Related]
4. Eukaryotic pathways targeted by the type III secretion system effector protein, BipC, involved in the intracellular lifecycle of Burkholderia pseudomallei.
Kang WT; Vellasamy KM; Vadivelu J
Sci Rep; 2016 Sep; 6():33528. PubMed ID: 27634329
[TBL] [Abstract][Full Text] [Related]
5. Role for the Burkholderia pseudomallei type three secretion system cluster 1 bpscN gene in virulence.
D'Cruze T; Gong L; Treerat P; Ramm G; Boyce JD; Prescott M; Adler B; Devenish RJ
Infect Immun; 2011 Sep; 79(9):3659-64. PubMed ID: 21768285
[TBL] [Abstract][Full Text] [Related]
6.
Kang WT; Vellasamy KM; Rajamani L; Beuerman RW; Vadivelu J
PeerJ; 2016; 4():e2532. PubMed ID: 28028452
[TBL] [Abstract][Full Text] [Related]
7. An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen.
Stevens MP; Wood MW; Taylor LA; Monaghan P; Hawes P; Jones PW; Wallis TS; Galyov EE
Mol Microbiol; 2002 Nov; 46(3):649-59. PubMed ID: 12410823
[TBL] [Abstract][Full Text] [Related]
8. BopC is a type III secreted effector protein of Burkholderia pseudomallei.
Muangman S; Korbsrisate S; Muangsombut V; Srinon V; Adler NL; Schroeder GN; Frankel G; Galyov EE
FEMS Microbiol Lett; 2011 Oct; 323(1):75-82. PubMed ID: 22092682
[TBL] [Abstract][Full Text] [Related]
9. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis.
Stevens MP; Haque A; Atkins T; Hill J; Wood MW; Easton A; Nelson M; Underwood-Fowler C; Titball RW; Bancroft GJ; Galyov EE
Microbiology (Reading); 2004 Aug; 150(Pt 8):2669-2676. PubMed ID: 15289563
[TBL] [Abstract][Full Text] [Related]
10. Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents.
Druar C; Yu F; Barnes JL; Okinaka RT; Chantratita N; Beg S; Stratilo CW; Olive AJ; Soltes G; Russell ML; Limmathurotsakul D; Norton RE; Ni SX; Picking WD; Jackson PJ; Stewart DI; Tsvetnitsky V; Picking WL; Cherwonogrodzky JW; Ketheesan N; Peacock SJ; Wiersma EJ
FEMS Immunol Med Microbiol; 2008 Jan; 52(1):78-87. PubMed ID: 17995960
[TBL] [Abstract][Full Text] [Related]
11. Burkholderia pseudomallei type III secretion system cluster 3 ATPase BsaS, a chemotherapeutic target for small-molecule ATPase inhibitors.
Gong L; Lai SC; Treerat P; Prescott M; Adler B; Boyce JD; Devenish RJ
Infect Immun; 2015 Apr; 83(4):1276-85. PubMed ID: 25605762
[TBL] [Abstract][Full Text] [Related]
12. Burkholderia thailandensis as a model system for the study of the virulence-associated type III secretion system of Burkholderia pseudomallei.
Haraga A; West TE; Brittnacher MJ; Skerrett SJ; Miller SI
Infect Immun; 2008 Nov; 76(11):5402-11. PubMed ID: 18779342
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive identification of virulence factors required for respiratory melioidosis using Tn-seq mutagenesis.
Gutierrez MG; Yoder-Himes DR; Warawa JM
Front Cell Infect Microbiol; 2015; 5():78. PubMed ID: 26583079
[TBL] [Abstract][Full Text] [Related]
14. Characterization of BcaA, a putative classical autotransporter protein in Burkholderia pseudomallei.
Campos CG; Borst L; Cotter PA
Infect Immun; 2013 Apr; 81(4):1121-8. PubMed ID: 23340315
[TBL] [Abstract][Full Text] [Related]
15. BPSS1504, a cluster 1 type VI secretion gene, is involved in intracellular survival and virulence of Burkholderia pseudomallei.
Hopf V; Göhler A; Eske-Pogodda K; Bast A; Steinmetz I; Breitbach K
Infect Immun; 2014 May; 82(5):2006-15. PubMed ID: 24595140
[TBL] [Abstract][Full Text] [Related]
16. The Burkholderia pseudomallei Proteins BapA and BapC Are Secreted TTSS3 Effectors and BapB Levels Modulate Expression of BopE.
Treerat P; Alwis P; D'Cruze T; Cullinane M; Vadivelu J; Devenish RJ; Prescott M; Adler B; Boyce JD
PLoS One; 2015; 10(12):e0143916. PubMed ID: 26624293
[TBL] [Abstract][Full Text] [Related]
17. Burkholderia pseudomallei known siderophores and hemin uptake are dispensable for lethal murine melioidosis.
Kvitko BH; Goodyear A; Propst KL; Dow SW; Schweizer HP
PLoS Negl Trop Dis; 2012; 6(6):e1715. PubMed ID: 22745846
[TBL] [Abstract][Full Text] [Related]
18. The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease?
Lazar Adler NR; Govan B; Cullinane M; Harper M; Adler B; Boyce JD
FEMS Microbiol Rev; 2009 Nov; 33(6):1079-99. PubMed ID: 19732156
[TBL] [Abstract][Full Text] [Related]
19. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.
Galyov EE; Brett PJ; DeShazer D
Annu Rev Microbiol; 2010; 64():495-517. PubMed ID: 20528691
[TBL] [Abstract][Full Text] [Related]
20. Peptidyl-Prolyl Isomerase
Bzdyl NM; Scott NE; Norville IH; Scott AE; Atkins T; Pang S; Sarovich DS; Coombs G; Inglis TJJ; Kahler CM; Sarkar-Tyson M
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331957
[No Abstract] [Full Text] [Related]
[Next] [New Search]